Semaglutide provides multifaceted kidney protection and improves structural markers in patients with T2D and chronic kidney disease.

Elevated menopause proteomic scores are associated with poorer cognitive outcomes and increased risk for Alzheimer disease and dementia.

Dual-hormone fully closed-loop therapy increases time in glycemic range compared with multiple daily insulin injections (MDI), but not compared with hybrid closed-loop (HCL) therapy in adults with ...

Retatrutide therapy significantly decreases body weight and improves knee osteoarthritis pain and events in OSA in adults with obesity.

Sustained smoking cessation for at least 8 years significantly reduces risk for microvascular complications in patients with type 2 diabetes.

GLP-1 RAs and SGLT-2 inhibitors reduce risk for renal deterioration in patients with type 2 diabetes (T2D) and albuminuria.

Physicians practicing in health professional shortage areas are more likely to remain in their roles when community integration and needs are met.

Women looking for relief from menopause symptoms could soon have a more affordable option for a weekly hormone patch.

Masked hypertension (higher home than office blood pressure [BP]) is associated with a higher risk for falls in older adults.

High-dose oral menopausal hormone therapy increases risk for venous thromboembolism, ischemic stroke, and myocardial infarction.

Off-label testosterone prescriptions for women have surged; most are not for the approved indication of hypoactive sexual ...

Once-weekly semaglutide promotes significant weight loss and improves cardiometabolic health in Asian adults with lower BMI thresholds.